Integrative multi-omics analysis of bile acid metabolism as a prognostic determinant in colorectal cancer
6 affiliations
- 1Gastroenterology and Liver Diseases Research Centre, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences
- 2Transplant Research Center, Clinical Research Institute, Mashhad University of Medical Sciences
- 3Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Centre, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences
- 4Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences
- 5Endoscopic and Minimally Invasive Surgery Research Center, Mashhad University of Medical Sciences
- 6Cellular and Molecular Research Center, Birjand University of Medical Sciences
Abstract
Metabolic reprogramming is a hallmark of colorectal cancer (CRC), yet the prognostic role of the bile acid metabolism pathway, regulated by host genetics and gut microbiota, remains poorly understood. We utilized an integrative multi-omics framework, combining bulk transcriptomics, single-cell, and spatial transcriptomics with microbiome data, to systematically dissect the prognostic significance of this pathway. The analysis was validated by experimental qRT-PCR on paired patient tumor and normal tissues. The pathway exhibited widespread transcriptional suppression in CRC tumors, a finding confirmed by the development of a 15-gene prognostic signature that demonstrated consistent prognostic association with overall survival across five independent cohorts. Single-cell analysis demonstrated that bile acid activity is suppressed across epithelial tumor subsets. Crucially, spatial transcriptomics provided cellular context, revealing that the pathway’s activity is distinctly enriched in metastatic stromal and CMS3 tumor microenvironment (TME) niches. Furthermore, the pathway’s activity was significantly correlated with gut microbiota composition, identifying key associated taxa (Clostridiales positive, Dorea longicatena negative). Collectively, these integrated findings suggest that suppression of the bile acid metabolism pathway is associated with prognosis in CRC and support further investigation of this pathway as a prognostically relevant feature of CRC. This comprehensive multi-omics analysis, supported by qRT-PCR validation of the significant downregulation of representative pathway genes (including ABCA8 and ABCD2), provides a framework for hypothesis-driven biomarker discovery and future investigation of therapeutic strategies targeting bile acid metabolism.
Related
- Integrated Transcriptomic Analysis Identifies ENO3 as a Candidate Lactate Metabolism‐Associated Biomarker in Colorectal Cancer Metastasis
- Kinase-based molecular subtyping and a prognostic risk model in colorectal cancer with functional validation of PLK4
- Prognostic value of the neutrophil-to-lymphocyte ratio in patients with colorectal cancer undergoing chemotherapy: a systematic review and meta-analysis
- Integrative genomics and experimental validation identify a mechanosensitive gene signature associated with colorectal cancer liver metastasis
- CAST as a Tumor-Specific Suppressor in Colorectal Cancer: Discovery Through Integrative Analysis of Unannotated Isoforms, Proteomics, and Epigenetic Regulation
BibTeX
@article{raeisi2026integrative,
title = {{Integrative multi-omics analysis of bile acid metabolism as a prognostic determinant in colorectal cancer}},
author = {Hamideh Raeisi and Rozita Khodashahi and Mahsa Saeedi Niasar and Samira Saghafi and Abbas Abdollahi and Amir Sadeghi and Hossein Safarpour},
journal = {Scientific Reports},
year = {2026},
month = jul,
doi = {10.1038/s41598-026-62474-7},
url = {https://doi.org/10.1038/s41598-026-62474-7},
note = {CC BY},
}
RIS
TY - JOUR
TI - Integrative multi-omics analysis of bile acid metabolism as a prognostic determinant in colorectal cancer
AU - Hamideh Raeisi
AU - Rozita Khodashahi
AU - Mahsa Saeedi Niasar
AU - Samira Saghafi
AU - Abbas Abdollahi
AU - Amir Sadeghi
AU - Hossein Safarpour
PY - 2026
DA - 2026/07/01
JO - Scientific Reports
DO - 10.1038/s41598-026-62474-7
UR - https://doi.org/10.1038/s41598-026-62474-7
AB - Metabolic reprogramming is a hallmark of colorectal cancer (CRC), yet the prognostic role of the bile acid metabolism pathway, regulated by host genetics and gut microbiota, remains poorly understood. We utilized an integrative multi-omics framework, combining bulk transcriptomics, single-cell, and spatial transcriptomics with microbiome data, to systematically dissect the prognostic significance of this pathway. The analysis was validated by experimental qRT-PCR on paired patient tumor and normal tissues. The pathway exhibited widespread transcriptional suppression in CRC tumors, a finding confirmed by the development of a 15-gene prognostic signature that demonstrated consistent prognostic association with overall survival across five independent cohorts. Single-cell analysis demonstrated that bile acid activity is suppressed across epithelial tumor subsets. Crucially, spatial transcriptomics provided cellular context, revealing that the pathway’s activity is distinctly enriched in metastatic stromal and CMS3 tumor microenvironment (TME) niches. Furthermore, the pathway’s activity was significantly correlated with gut microbiota composition, identifying key associated taxa (Clostridiales positive, Dorea longicatena negative). Collectively, these integrated findings suggest that suppression of the bile acid metabolism pathway is associated with prognosis in CRC and support further investigation of this pathway as a prognostically relevant feature of CRC. This comprehensive multi-omics analysis, supported by qRT-PCR validation of the significant downregulation of representative pathway genes (including ABCA8 and ABCD2), provides a framework for hypothesis-driven biomarker discovery and future investigation of therapeutic strategies targeting bile acid metabolism.
SN - 2045-2322
ER -